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Edited by Laszlo NagyAbstract Ovulation is a complex process initiated by the surge
of the pituitary luteinizing hormone (LH) that provokes the
expression of speciﬁc genes. We report herein the isolation and
characterization of an ovulation-associated, ovary-speciﬁc novel
isoform of epoxide hydrolase 2 (Ephx2), Ephx2C. This variant is
exclusively expressed in the granulosa cells of preovulatory
mouse ovarian follicles. The LH-induced expression of Ephx2C
is mediated by the protein kinase A and partially by the protein
kinase C signaling pathways. The involvement of p38 kinase has
also been demonstrated.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The release of the female gamete from the ovary, known as
ovulation, is a key event in mammalian reproduction. Success-
ful ovulation is a complex process by which mature ovarian
follicles respond to the surge of the pituitary luteinizing hor-
mone (LH) and rupture to release fertilizable oocytes. LH acts
on mature follicles to down-regulate the expression of genes
associated with folliculogenesis and stimulates the up-regula-
tion of other speciﬁc genes involved in ovulation. Genes
known to be induced by LH during the ovulatory process in-
clude the progesterone receptor (PR), cycloosygenase-2
(COX-2), CAAT enhancer binding protein b (reviewed at
[1]), amphiregulin [2], receptor-interacting protein 140 [3],
endothelin-2 [4], and others recently documented by micro-Abbreviations: LH, luteinizing hormone; RT-PCR, reverse transcrip-
tase polymerase chain reaction; SSH, suppression subtractive hybrid-
ization method; EETs, epoxyeicosatrienoic acids; hCG, human
chorionic gonadotropin; PMSG, pregnant mare’s serum gonadotro-
pin; MML-V, moloney murine leukemia virus; FSK, forskolin; TPA,
tetradecanoyl phorbol acetate; BLASTn, basic local alignment search
tool nucleotide; BLAT, BLAST-like alignment tool; RACE, rapid
ampliﬁcation of the cDNA ends; ORF, open reading frame; PKC,
protein kinase C; PKA, protein kinase A; PLC, phospholipase C;
DAG, diacyl glycerol
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doi:10.1016/j.febslet.2007.09.016array analysis [5,6] and diﬀerential display reverse transcrip-
tase polymerase chain reaction (RT-PCR) [7].
The function of some of the above mentioned genes as essen-
tial players in the ovulatory cascade has been identiﬁed,
whereas, the role of others, the expression of which is up-regu-
lated following the LH surge, awaits further investigation. Fur-
thermore, identiﬁcation of new crucial participants in this
highly complex cascade leading to ovulation is of major signif-
icance. Along this line, we have previously applied the SSH
method [8] in order to systematically isolate genes with an ovu-
lation-selective pattern of expression [9]. In the present work,
we employed bioinformatics search tools to select cDNA clones
with a preference for those representing putative novel genes.
During preliminary characterization of the ovulatory-depen-
dent novel cDNAs, one such clone, 4E4, was identiﬁed as a no-
vel splice variant of epoxide hydrolase 2 (Ephx2), predicted to
encode for a yet unknown isoform of the protein. Epoxide
hydrolases are enzymes that convert epoxide substrates to their
corresponding less potent vicinal diols [10]. One class of such
substrates for the EPHX2 protein includes epoxyeicosatrienoic
acids (EETs), molecules generated by cytochrome P450 epox-
idation of arachidonic acid. EETs and/or EET diols have been
shown to induce changes in a variety of events associated with
ovulation, such as theca internal blood ﬂow [11], prostaglandin
E2 production [12], COX-2 expression [13], estradiol biosyn-
thesis [14], and plasminogen activator expression [15]. For that
reason, one could anticipate dynamic changes in EET produc-
tion in the hours preceding ovulation. Moreover, a recently
published paper has reported the existence of an additional
variant of Ephx2, Ephx2B, whose expression is also regulated
by LH/hCG [16].
We herein report of identiﬁcation of an ovary-restricted ovu-
lation-associated novel isoform of Ephx2, Ephx2C.2. Materials and methods
2.1. Animals
Sexually immature 24-day-old female C57BL/6 mice were purchased
from Harlan (Harlan Laboratories, Rehovot, Israel) and handled at
the Animal Breeding Center of the Weizmann Institute of Science.
All experiments were conducted in accordance with the NIH Guide-
lines. The animals were subcutaneously injected with 5 IU pregnant
mare’s serum gonadotropin (PMSG) (Chrono-gest Intervest), followed
by 5 IU human chorionic gonadotropin (hCG) (N.V. Organon Oss),
intraperitoneally injected 48 h later. The mice were killed by cervical
dislocation; the ovaries were removed at diﬀerent time points before
and after hCG administration and incubated in RNA Later (Ambion)
for RNA puriﬁcation.blished by Elsevier B.V. All rights reserved.
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Standard protocols were used, and details are provided in Supple-
mental data.
2.3. Relative Real-time PCR
4E4 primers were designed using Beacon designer software
(Bio-Rad) and analyzed by BLAST-like alignment tool (BLAT) for
their speciﬁcity (Table 1, Supplemental data). All Real-time PCRs were
carried out using the iCycler iQ Detection System (Bio-Rad) and the
DyNAmo SYBR Green qPCR Kit (Finnzymes) according to the man-
ufacturer’s instructions. Details of the reaction protocols are provided
in Supplemental data.
2.4. Full-length cDNA sequence determination (RACE)
The 5 0 and 3 0 ends of the 4E4 cDNA were determined by the
SMART rapid ampliﬁcation of the cDNA ends (RACE) cDNA
Ampliﬁcation Kit (Clontech), according to the manufacturer’s instruc-
tions. PCR products were puriﬁed, cloned and sequenced as detailed in
Supplemental data.
2.5. Multiple tissue array
Diﬀerent tissues were isolated from two immature PMSG/hCG-
treated (5 h after hCG administration) as well as from two untreated
female mice. Additional tissues were isolated from two sexually ma-
ture and two immature male C57BL/6 mice. Animals were perfused
with cold PBS solution (Invitrogen life technologies) prior to tissue
dissection. Total RNA was isolated and semi-quantitative RT-PCR
ampliﬁcation of the designated splice variants was performed (35 cy-
cles for each variant, 24 cycles for b-actin). The resultant PCR prod-
ucts were separated on a 1.5% agarose gel stained with ethidium
bromide.
2.6. In situ hybridization
Protocol for in situ hybridization is provided in the Supplemental
data.
2.7. Culture of follicles
Isolated intact, large antral ovarian follicles were recovered from
sexually immature PMSG-primed 25-day-old female C57BL mice
and grown in suspension of Leibovitz’s L-15 tissue culture medium
containing 5% fetal bovine serum (Biological Industries, Kibbutz Beit
Hemeek, Israel) in 25-ml ﬂasks gassed with 50% O2 + 50% N2. Incuba-
tions were carried out at 37 C in an oscillating water bath with or
without 1 lg/ml ovine LH (National Institutes of Health LH S-24) in
the presence or absence of one of the reagents designated in Fig. 5
and detailed in Supplemental data.Fig. 1. Ovulation-associated expression pattern of the novel 4E4 clone by Re
PMSG-primed, no hCG), and PMSG-primed mice at the designated time po
control. Error bars represent the standard error of the mean (n = 3 indep
diﬀerent (P < 0.05) relative to control.3. Results and discussion
3.1. The expression of 4E4 is transiently elevated in an
ovulation-associated manner
We have previously reported that using the diﬀerential
screening technique SSH [9] we isolated 252 cDNA clones that
are either selectively or exclusively expressed during ovulation
in the mouse ovary. In the present study, we employed a
BLASTn analysis in combination with BLAT to select cDNA
clones with a preference for those representing putative novel
genes.
One such novel cDNA clone, 4E4, was selected for further
validation of its ovulation-associated expression pattern.
Real-time PCR analysis of ovarian cDNA demonstrated a
15-fold increase of the 4E4 transcript expression at 4 h after
hCG administration. This elevation was sustained up to the
time of ovulation (12–14 h after hCG treatment) and dropped
to near baseline levels at 24–48 h after hCG injection (Fig. 1).
This pattern of 4E4 expression suggests a possible function for
this gene during the ovulatory process.
3.2. Ephx2C – a novel isoform of Ephx2
Initial characterization of the 4E4 clone by BLAT revealed a
perfect match between the last 9 bp of 4E4 and the ﬁrst 9 bp of
exon 3 of the Ephx2 gene; the majority of the sequence has no
homology to any sequence entries, however it aligned perfectly
to the genome directly upstream of Ephx2 exon 3. This implied
that 4E4 is part of a new exon of a novel Ephx2 splice variant.
Since SSH yields only partial cDNA fragments (393 bp for
4E4), RACE was employed on ovarian cDNA to isolate the
full-length sequence. In response to hCG treatment, this geno-
mic region is highly transcriptionally active, and several RACE
products were detected. Four distinct new splice variants of the
gene were isolated. We chose to characterize the major tran-
script, which also had the longest open reading frame, and
the strongest response to hCG (data not shown). The 5 0 and
3 0 RACE products of the major isoform, 350 bp and
2000 bp, respectively (Fig. 2A) were isolated, cloned and se-
quenced. The full-length cDNA sequence (Fig. 2B) was sub-al-time PCR. Ovarian RNA was isolated from untreated, control (0 h,
ints after hCG administration. The mRNA expression is relative to the
endent in vivo experiments). Columns with asterisks are signiﬁcantly
Fig. 2. The full-length cDNA sequence of clone 4E4, as determined by RACE, corresponds to a novel isoform of soluble epoxide hydrolase. (A) The
PCR products from the 5 0 and 3 0 RACE reactions. (B) Nucleotide and deduced amino acid sequence of Ephx2C. Marked nucleotide sequences
represent primer sequences used for RACE analysis. (C) Genomic structure of the Ephx2 isoforms. Ephx2 is located on the mouse genome (NCBI
version 36) chr14:65,038,487–65,078,610. The location of 4E4 is also shown. (D) Amino acid alignment of Ephx2, Ephx2B and Ephx2C proteins.
Symbols: () indicate the key catalytic Asp residue required for lipid phosphatase activity, (d) divalent cation or phosphate binding amino acids, and
(r) catalytic triad necessary for epoxide hydrolase activity. Arrow indicates approximate junction between phosphatase and epoxide hydrolase
domains (as detailed in [16]).
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ilarity to the Ephx2 gene (NM_007940), as well as to a recently
identiﬁed isoform of this gene, Ephx2B (AY098585) [16]
(Fig. 2C). Based on the signiﬁcant level of overlap between
these sequences, the ovulation-selective cDNA sequence has
been referred to as Ephx2C (EF597241). It is a new splice var-
iant, with a unique 5 0 exon, distinct from the ﬁrst exons of the
previously identiﬁed isoforms (Fig. 2C). From the full-length
Ephx2C cDNA sequence, a single open reading frame was
identiﬁed that can encode for a protein of 488 amino acids
(Fig. 2D). The putative protein products of Ephx2, Ephx2B
and Ephx2C overlap through most of their length and diﬀeronly within the N-terminus (Fig. 2D). The segment of the
protein conserved between the three isoforms contains the
catalytic domain responsible for epoxide hydrolase activity
[17].3.3. Tissue expression proﬁle of Ephx2, Ephx2B and Ephx2C
To assess the speciﬁcity of expression of the various Ephx2
isoforms in diverse mouse tissues, RNA was extracted and sub-
jected to semi-quantitative RT-PCR analysis using speciﬁc
primers for each splice variant. The forward primer for each
PCR product corresponded to the unique ﬁrst exon of each
Fig. 3. Ovary-speciﬁc and ovulation-associated expression proﬁle of the novel Ephx2C isoform. Tissue expression proﬁle of Ephx2, Ephx2B and the
novel Ephx2C isoform in female and male mouse tissues. A representative experiment is shown (n = 3). In the Ephx2B panel, the upper band is the
published isoform, and in the Ephx2C panel, the lower band is the published isoform.
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The primers for Ephx2C can also identify one of the additional
splice variants isolated by us, which is 136 bp longer. To ensure
the speciﬁcity of the correct band, all the PCR products were
sequenced. As shown in Fig. 3, Ephx2C expression was de-
tected exclusively in ovarian tissue with a signiﬁcant increase
following hCG administration, whereas the Ephx2, as ex-
pected, had a wide range of tissue expression. Ephx2B was
highly abundant in ovarian tissue; however, its expression is
detected in other tissues as well (Fig. 3). This is inconsistent
with the previously reported ovary-selective expression [16].
Importantly, the mRNA level of the Ephx2B isoform was ele-
vated to a much lesser extent as compared to the Ephx2C iso-
form that showed a dramatic increase in expression following
hCG administration.
These results indicate that we have identiﬁed a new ovary-
speciﬁc and ovulation-associated isoform of Ephx2. Overall,
the variability in tissue expression of the three isoforms sug-
gests a distinct role of each isoform in the particular tissues.
3.4. Spatial characterization of Ephx2C expression pattern in
the mouse ovary
Using a speciﬁc riboprobe for the Ephx2C variant, which
cannot detect any of the other splice variants, in situ hybridiza-
tion was performed. These experiments revealed that the mes-
sage encoding Ephx2C is expressed in both granulosa and
cumulus cells of the large antral follicles, with no detectablesignal in either the oocyte or the theca cells (Figs. 4B and
D). Time course analysis conﬁrmed that Ephx2C mRNA
expression increases from undetectable levels at 48 h after
PMSG (Fig. 4E) to high levels at 8 h after hCG (Figs. 4B
and D) followed by a drop to undetectable levels at 24 h after
hCG administration (Fig. 4F). To note, it was previously
shown that the Ephx2 and Ephx2B isoforms are also expressed
in the granulosa cell compartment of the ovary prior to ovula-
tion but at non-overlapping phases [16].
3.5. Characterization of the signaling cascade leading to up-
regulation of Ephx2 isoforms
It was previously shown that LH activates both the protein
kinase A (PKA) and the protein kinase C (PKC) signaling path-
ways to induce the expression of preovulatory genes, such as
COX-2 [18] and PR [19]. To investigate which intracellular sig-
naling pathways are involved in the LH-induced up-regulation
of Ephx2CmRNA, we by-passed the hormone receptor interac-
tion by activating down-stream regulators of the LH signaling
cascade. In addition, in a set of complementary experiments,
we employed speciﬁc inhibitors of these signaling pathways.
These experiments were performed in vitro on isolated intact
large antral ovarian follicles. Real-time PCR analysis was per-
formed with primers that were speciﬁc to each isoform.
As shown in Fig. 5A, LH stimulated a substantial increase in
Ephx2B and Ephx2C mRNA expression in these follicles
(P < 0.05). Forskolin (FSK), an activator of adenylate cyclase
Fig. 4. Localization of Ephx2C mRNA in the ovary by in situ hybridization. (A+C) Sense probe hybridization (B+D) Antisense probe hybridization.
(A–D): tissues were isolated 8 h after hCG administration. E, no hCG treatment; F, 24 h after hCG administration. Gc, granulosa cell layer; Th,
theca cell layer; O, oocyte; PF, preovulatory follicles; F, follicles.
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to that of LH, whereas the PKC activator, tetradecanoyl phor-
bol acetate, stimulated the Ephx2C expression to a much lesser
extent, with no eﬀect on Ephx2B expression (Fig. 5A). In
agreement with the above ﬁndings the eﬀect of LH on Ephx2B
and Ephx2C mRNA expression was prevented by H89, a spe-
ciﬁc inhibitor of PKA, whereas the inhibitor of PKC,
GF109203, exhibited only a partial eﬀect on LH action (Figs.
5A and B). Ephx2 mRNA expression was not stimulated by
LH, and seems not to be regulated by any of these pathways.
It was previously published [20] that in preovulatory granu-
losa cells hCG induces the activation of MEK and p42/44
MAPK through the cAMP/PKA-dependent pathway, but also
stimulates p38-kinase phosphorylation independently of PKA
and PKC. Indeed, UO126, a speciﬁc inhibitor of MEK, re-
duced the mRNA expression of Ephx2B and Ephx2C almost
completely. SB202190, a speciﬁc inhibitor of the p38 MAPK,inhibited Ephx2C almost completely, while showing a much
lesser eﬀect on Ephx2B.
Taken together, our results indicate that the LH-induced
mRNA expression of Ephx2 isoforms is mediated by various
intracellular signaling molecules, including AC, PKA, MEK,
PKC and p38 kinase. However, there are diﬀerences between
the various isoforms: Ephx2 expression is not stimulated at
all by LH; Ephx2B expression is stimulated by the PKA
pathway, and to a much lesser extent by p38 MAPK;
Ephx2C expression is stimulated equally by PKA and p38
MAPK, and in addition, it is partially stimulated by PKC
(Fig. 5B).
To conclude, Ephx2C is a novel ovary speciﬁc isoform of
Ephx2 that is distinct from both Ephx2 and Ephx2B and is
highly expressed in response to the ovulatory stimulus. Its
LH-induced mRNA expression involves the PKA and p38
MAPK pathways, and to a lesser extent PKC. More studies
Fig. 5. Regulation of Ephx2C mRNA expression in murine follicles in vitro. (A) Follicles were incubated with various activators or inhibitors of
either PKA, PKC or MAPK signaling pathways, and expression levels of Ephx2, Ephx2B, and Ephx2C mRNA were assessed by Real-time PCR.
Error bars represent the standard error of the mean (n = 3–6 independent culture experiments; each sample included follicles from 3 to 4 mice). (B)
Schematic presentation of the results. Full arrows – full activation/suppression, dashed arrows – partial activation/suppression.
K. Shkolnik et al. / FEBS Letters 581 (2007) 4891–4898 4897are needed to elucidate the exact role of this novel isoform in
ovulation.
Acknowledgements: The authors would like to thank Dr. N. Nevo for
animal handling for the tissue array assay. This study was supported in
part by grants from the Center for Women’s Health Research, WIS
Chief Scientist Oﬃce, Israel ministry of Health; the Israel Science foun-
dation (682/04); and the Dwek Fund for Biomedical Research. N. De-
kel is the incumbent of the Philip M. Klutznick Professional Chair in
Developmental Biology.Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.febslet.2007.09.016.References
[1] Richards, J.S., Russell, D.L., Ochsner, S. and Espey, L.L. (2002)
Ovulation: new dimensions and new regulators of the inﬂamma-
tory-like response. Annu. Rev. Physiol. 64, 69–92.
[2] Park, J.Y., Su, Y.Q., Ariga, M., Law, E., Jin, S.L. and Conti, M.
(2004) EGF-like growth factors as mediators of LH action in the
ovulatory follicle. Science 303, 682–684.
[3] Tullet, J.M., Pocock, V., Steel, J.H., White, R., Milligan, S. and
Parker, M.G. (2005) Multiple signaling defects in the absence ofRIP140 impair both cumulus expansion and follicle rupture.
Endocrinology 146, 4127–4137.
[4] Ko, C., Gieske, M.C., Al-Alem, L., Hahn, Y., Su, W., Gong,
M.C., Iglarz, M. and Koo, Y. (2006) Endothelin-2 in ovarian
follicle rupture. Endocrinology 147, 1770–1779.
[5] Jo, M., Gieske, M.C., Payne, C.E., Wheeler-Price, S.E., Gieske,
J.B., Ignatius, I.V., Curry Jr., T.E. and Ko, C. (2004) Develop-
ment and application of a rat ovarian gene expression database.
Endocrinology 145, 5384–5396.
[6] Leo, C.P., Pisarska, M.D. and Hsueh, A.J. (2001) DNA array
analysis of changes in preovulatory gene expression in the rat
ovary. Biol. Reprod. 65, 269–276.
[7] Espey, L.L. and Richards, J.S. (2002) Temporal and spatial
patterns of ovarian gene transcription following an ovulatory
dose of gonadotropin in the rat. Biol. Reprod. 67, 1662–1670.
[8] Diatchenko, L., Lau, Y.F., Campbell, A.P., Chenchik, A.,
Moqadam, F., Huang, B., Lukyanov, S., Lukyanov, K., Gurs-
kaya, N., Sverdlov, E.D. and Siebert, P.D. (1996) Suppression
subtractive hybridization: a method for generating diﬀerentially
regulated or tissue-speciﬁc cDNA probes and libraries. Proc.
Natl. Acad. Sci. USA 93, 6025–6030.
[9] Hourvitz, A., Gershon, E., Hennebold, J.D., Elizur, S., Maman,
E., Brendle, C., Adashi, E.Y. and Dekel, N. (2006) Ovulation-
selective genes: the generation and characterization of an ovula-
tory-selective cDNA library. J. Endocrinol. 188, 531–548.
[10] Newman, J.W., Morisseau, C. and Hammock, B.D. (2005)
Epoxide hydrolases: their roles and interactions with lipid
metabolism. Prog. Lipid. Res. 44, 1–51.
[11] Brannstrom, M., Zackrisson, U., Hagstrom, H.G., Josefsson, B.,
Hellberg, P., Granberg, S., Collins, W.P. and Bourne, T. (1998)
4898 K. Shkolnik et al. / FEBS Letters 581 (2007) 4891–4898Preovulatory changes of blood ﬂow in diﬀerent regions of the
human follicle. Fertil. Steril. 69, 435–442.
[12] Fang, X., Moore, S.A., Stoll, L.L., Rich, G., Kaduce, T.L.,
Weintraub, N.L. and Spector, A.A. (1998) 14,15-Epoxyeicosatri-
enoic acid inhibits prostaglandin E2 production in vascular
smooth muscle cells. Am. J. Physiol. 275, H2113–H2121.
[13] Peri, K.G., Varma, D.R. and Chemtob, S. (1997) Stimulation of
prostaglandin G/H synthase-2 expression by arachidonic acid
monoxygenase product, 14,15-epoxyeicosatrienoic acid. FEBS
Lett. 416, 269–272.
[14] Van Voorhis, B.J., Dunn, M.S., Falck, J.R., Bhatt, R.K.,
VanRollins, M. and Snyder, G.D. (1993) Metabolism of arachi-
donic acid to epoxyeicosatrienoic acids by human granulosa cells
may mediate steroidogenesis. J. Clin. Endocrinol. Metab. 76,
1555–1559.
[15] Reinthaller, A., Kirchheimer, J.C., Deutinger, J., Bieglmayer, C.,
Christ, G. and Binder, B.R. (1990) Plasminogen activators,
plasminogen activator inhibitor, and ﬁbronectin in human gran-
ulosa cells and follicular ﬂuid related to oocyte maturation and
intrafollicular gonadotropin levels. Fertil. Steril. 54, 1045–1051.[16] Hennebold, J.D., Mah, K., Perez, W., Vance, J.E., Stouﬀer, R.L.,
Morisseau, C., Hammock, B.D. and Adashi, E.Y. (2005) Iden-
tiﬁcation and characterization of an ovary-selective isoform of
epoxide hydrolase. Biol. Reprod. 72, 968–975.
[17] Grant, D.F., Storms, D.H. and Hammock, B.D. (1993) Molecular
cloning and expression of murine liver soluble epoxide hydrolase.
J. Biol. Chem. 268, 17628–17633.
[18] Morris, J.K. and Richards, J.S. (1995) Luteinizing hormone
induces prostaglandin endoperoxide synthase-2 and luteinization
in vitro by A-kinase and C-kinase pathways. Endocrinology 136,
1549–1558.
[19] Natraj, U. and Richards, J.S. (1993) Hormonal regulation,
localization, and functional activity of the progesterone receptor
in granulosa cells of rat preovulatory follicles. Endocrinology 133,
761–769.
[20] Salvador, L.M., Maizels, E., Hales, D.B., Miyamoto, E.,
Yamamoto, H. and Hunzicker-Dunn, M. (2002) Acute signaling
by the LH receptor is independent of protein kinase C activation.
Endocrinology 143, 2986–2994.
